Ultragenyx (RARE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.62B
Last updated: Nov 17, 2026 at 4:37 PM ET
Ultragenyx (RARE) Stock Chart
Ultragenyx (RARE) has a latest price of $16.70 on Nov 17, 2026, 58.1% below its 52-week high of $39.89. Its price fell 49.5% over the past 12 months. The month-end price fell 72.7% over the 10 years through Oct 2026, a compound annual decline of 12.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $141.54 in Feb 2021 and its lowest $15.03 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RARE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RARE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 36.4%, and over 6 months it fell 25.6%. The month-end price fell 54.5% over the 3 years through Oct 2026, a compound annual decline of 23.1%.
| Period | Change |
|---|---|
| 1 month | +10.8% |
| 3 months | -36.4% |
| 6 months | -25.6% |
| 12 months | -49.5% |
| 12 months, with dividends | -49.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -54.5% | -23.1% |
| 5 years | -80.8% | -28.1% |
| 10 years | -72.7% | -12.2% |
Price by Year
Its best calendar year was 2020, when the price rose 224.1%, and its weakest was 2025, when it fell 45.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $16.10 | -30.0% |
| 2025 | $23.00 | -45.3% |
| 2024 | $42.07 | -12.0% |
| 2023 | $47.82 | +3.2% |
| 2022 | $46.33 | -44.9% |
| 2021 | $84.09 | -39.3% |
| 2020 | $138.43 | +224.1% |
| 2019 | $42.71 | -1.8% |
| 2018 | $43.48 | -6.3% |
| 2017 | $46.38 | -34.0% |
Trading Range
The price is 8.9% above its 50-day average of $15.34 and 25.6% below its 200-day average of $22.45.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $16.70 | |
| 52-week high | $39.89 | -58.1% |
| 52-week low | $12.73 | +31.2% |
| 50-day average | $15.34 | +8.9% |
| 200-day average | $22.45 | -25.6% |
Price Risk
Over 3 years, its largest fall from a peak was 78.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.34 |
| Largest fall, 1 year | -64.8% |
| Largest fall, 3 years | -78.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RARE
What is RARE's 1-year price change?
Ultragenyx's price fell 49.5% over the past 12 months. With dividends included, the 12-month total return was -49.5%.
What is RARE's 5-year price change?
Ultragenyx's month-end price fell 80.8% over the 5 years through Oct 2026, a compound annual decline of 28.1%. These figures leave out dividends.
What is RARE's 52-week high and low?
Ultragenyx's 52-week high is $39.89 and its 52-week low is $12.73. Its latest price of $16.70 on Nov 17, 2026 is 58.1% below the high.
What is RARE's beta?
Ultragenyx's 1-year beta against the S&P 500 is 1.34, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 64.8%.
Is the RARE chart free?
Yes. Advanced Charting for RARE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RARE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors